The diagnosis of growth hormone deficiency in children and adults

Endocrine Reviews

Volumn 19, Issue 2, 1998, Pages 203-223

  Shalet, Stephen Michael ^a   Toogood, Andrew ^a   Rahim, Asad ^a   Brennan, Bernadette M D ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; PYRIDOSTIGMINE; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

AGING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MAJOR CLINICAL STUDY; MORBID OBESITY; ONSET AGE; PRIORITY JOURNAL; PROVOCATION TEST; REVIEW; SHORT STATURE;

EID: 0032434635     PISSN: 0163769X     EISSN: None     Source Type: Journal    
DOI: 10.1210/edrv.19.2.0329     Document Type: Review

References (219)

1. August GP, Lippe BM, Blethen L, Rosenfeld RG, Seelig SA, Johanson AJ, Compton PG, Frane JW, McClellan BH, Sherman BM 1990 Growth hormone treatment in the United States: demographic and diagnostic features of 2331 children. J Pediatr 116: 899-903
2. Vanderschueren-Lodeweyckx M 1994 History of growth hormone treatment and development of the Kabi International Growth Study. In: Ranke MB, Gunnarsson R (eds) Progress in Growth Hormone Therapy - 5 years of KIGS. Verlag, Mannheim, Germany, pp 37-50
3. Rosen T, Bengtsson BA 1990 Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 336:285-288
4. Toogood AA, Beardwell CG, Shalet SM 1994 The severity of growth hormone deficiency in adult pituitary disease is related to the degree of hypopituitarism. Clin Endocrinol (Oxf) 41:511-516
5. Lippe B, Frasier SD 1989 How should we test for growth hormone deficiency, and whom should we treat? J Pediatr 115:585-587
6. Rosenfeld RG, Albertsson-Wikland K, Cassorla F, Frasier SD, Hasegawa Y, Hintz RL, Lafranchi S, Lippe B, Loriaux L, Melmed S, Preece MA, Ranke MB, Reiter EO, Rogol AD, Underwood LE, Werther GA 1995 Diagnostic controversy: the diagnosis of childhood growth hormone deficiency revisited. J Clin Endocrinol Metab 80:1532-1540
7. Hindmarsh PC, Swift PGF 1995 An assessment of growth hormone provocation tests. Arch Dis Child 72:362-368
8. Dattani MT, Pringle PJ, Hindmarsh PC, Brook CGD 1992 What is a normal stimulated growth hormone concentration? J Endocrinol 133:447-450
9. Hindmarsh PC, Brook CGD 1995 Short stature and growth hormone deficiency. Clin Endocrinol (Oxf) 43:133-142
10. Ho KKY, Hoffman DM 1995 Defining growth hormone deficiency in adults. Metabolism 44:[Suppl 4]:91-96
11. DeBoer H, Blok GJ, Van der Veen EA 1995 Clinical aspects of growth hormone deficiency in adults. Endocr Rev 16:63-86
12. Korbonits M, Besser M 1996 Diagnosis of growth hormone deficiency in adults. Horm Res 46:174-182
13. Hindmarsh PC, Smith PJ, Brook CGD, Matthews DR 1987 The relationship between growth velocity and growth hormone secretion in short prepubertal children. Clin Endocrinol (Oxf) 27:581-591
14. Adan L, Souberbielle JC, Brauner R 1994 Diagnostic markers of permanent idiopathic growth hormone deficiency. J Clin Endocrinol Metab 78:353-358
15. Price DA 1996 Spontaneous adult height in patients with idiopathic short stature. Horm Res 45[Suppl 2]:59-63
16. Voss LD, Wilkin TJ, Bailey BJR, Betts PR 1991 The reliability of height and height velocity in the assessment of growth (the Wessex Growth Study). Arch Dis Child 66:833-837
17. Craft WH, Underwood LE, Van Wyk JJ 1980 High incidence of perinatal insult in children with idiopathic hypopituitarism. J Pediatr 96:397-402
18. Hoyt WF, Kaplan SL, Grumbach MM 1985 Hypothalamic-pituitary function in children with optic nerve hypoplasia. Am J Dis Child 1:893-894
19. Rudman D, Davis T, Priest JH, Patterson JH, Kutner MH, Heymsfield SB, Bethel RA 1978 Prevalence of growth hormone deficiency in children with cleft lip or palate. J Pediatr 91:378-382
20. Rappaport EB, Ulstrom RA, Gorlin RJ, Lucky AW, Collie E, Miser J 1977 Solitary maxillary central incisor and short stature. J Pediatr 91:924-928
21. Shalet SM, Crowne EC, Didi M, Ogilvy-Stuart AL, Wallace WHB 1992 Irradiation-induced growth failure. Baillieres Clin Endocrinol Metab 6:513-526
22. Broadbent V, Dunger DB, Yeomans E, Kendall B 1993 Anterior pituitary function and computed tomography/magnetic resonance imaging in patients with Langerhan's cell histiocytosis and diabetes insipidus. Med Pediatr Oncol 21:649-654
23. Kilpatrick SE, Wenger DE, Gilchrist GS, Shives TC, Wollan PC, Unni KK 1995 Langerhan's cell histiocytosis (histiocytosis X) of bone. A clinicopathologic analysis of 263 pediatric and adult cases. Cancer 76:2471-2484
24. Kuroiwa T, Okabe Y, Hasuo K, Yasumori K, Mizushima A, Masuda K 1991 MR imaging of pituitary dwarfism. AJNR 12:161-164
25. Argyropoulou M, Perignon F, Brauner R, Brunelle F 1992 Magnetic resonance imaging in the diagnosis of growth hormone deficiency. J Pediatr 120:886-891
26. Marwaha R, Menon PS, Jena A, Pant C, Sethi AK, Sapra ML 1992 Hypothalamo-pituitary axis by magnetic resonance imaging in isolated GH deficiency patients born by normal delivery. J Clin Endocrinol Metab 74:654-659
27. Andersson AM, Orskov H, Ranke MB, Shalet SM, Skakkebaek NE 1995 Interpretation of GH provocative tests: comparison of cut-off values in four European laboratories. Eur J Endocrinol 132: 340-343
28. Wyatt DT, Mark D, Slyper A 1995 Survey of growth hormone treatment practices by 251 pediatric endocrinologists. J Clin Endocrinol Metab 80:3292-3297
29. Gale EA, Bennett T, MacDonald IA, Holst JJ, Matthews JA 1983 The physiological effects of insulin-induced hypoglycaemia in man: responses at differing levels of blood glucose. Clin Sci 65: 263-271
30. Shah A, Stanhope R, Matthew D 1992 Hazards of pharmacological tests of growth hormone secretion in childhood. Br Med J 304:173-174
31. Raiti S, Davis WT, Blizzard RM 1967 A comparison of the effects of insulin hypoglycaemia and arginine infusion on release of human growth hormone. Lancet 2:1182-1183
32. Frasier SD 1974 A review of growth hormone stimulation tests in children. Pediatrics 53:929-937
33. Coller R, Leboeuf G, Letarte J 1975 Stimulation of growth hormone secretion by Levo-dopa propranolol in children and adolescents. Pediatrics 56:262-266
34. Merimee TJ, Rabinowitz D, Fineberg SE 1969 Arginine-initiated release of human growth hormone. N Engl J Med 280:1434-1438
35. Mitchell ML, Byrne MJ, Sanchez Y, Sawin CT 1970 Detection of growth hormone deficiency: the glucagon stimulation test. N Engl J Med 282:539-541
36. Gil-Ad I, Topper E, Laron Z 1979 Oral clonidine as a growth hormone stimulation test. Lancet 2:278-279
37. Rochiccioli P, Tauber M 1994 Growth hormone deficiency: establishment of the diagnosis by means of growth hormone secretion tests in the Kabi International Growth Study. In: Ranke MB, Gunnarsson R (eds) Progress in Growth Hormone Therapy - 5 years of KIGS. Verlag, Mannheim, Germany, pp 68-76
38. Penny R, Blizzard RM, Davis WT 1969 Sequential arginine and insulin tolerance tests on the same day. J Clin Endocrinol Metab 29:1499-1501
39. Fass B, Lippe BM, Kaplan SA 1979 Relative usefulness of three growth hormone stimulation screening tests. Am J Dis Child 133: 931-933
40. Weldon VV, Gupta SK, Klingensmith G, Clark WL, Duck SC, Haymond MW, Pagliara AS 1975 Evaluation of growth hormone release in children using arginine and L-dopa in combination. J Pediatr 87:540-544
41. Deller JJ, Boulis MW, Harriss WE, Hutsell TC, Garcia JF, Linfoot JA 1970 Growth hormone response patterns to sex hormone administration in growth retardation. Am J Med Sci 259:292-296
42. Martin LG, Clark JW, Connor TB 1968 Growth hormone secretion enhanced by androgens. J Clin Endocrinol Metab 28:425-428
43. Martha PM, Rogol AD, Veldhuis JD, Kerrigan JR, Goodman DW, Blizzard RM 1989 Alterations in the pulsatile properties of circulating growth hormone concentrations during puberty in boys. J Clin Endocrinol Metab 69:563-570
44. Rosenfeld RG 1982 Evaluation of growth and maturation in adolescence. Pediatr Rev 4:175-183
45. Finkelstein JW, Roffwarg HP, Boyar M, Kream J, Hellman L 1972 Age-related change in twenty four hour spontaneous secretion of growth hormone. J Clin Endocrinol Metab 35:665-670
46. Mauras N, Blizzard RM, Link K, Johnson ML, Rogol AD, Veldhuis JD 1987 Augmentation of growth hormone secretion during puberty: evidence for a pulse amplitude-modulated phenomenon. J Clin Endocrinol Metab 64:596-601
47. Martha PM, Gorman KM, Blizzard RM, Rogol AD, Veldhuis JD 1992 Endogenous growth hormone secretion and clearance rates in normal boys as determined by deconvolution analysis: relationship to age, pubertal status and body mass. J Clin Endocrinol Metab 74:336-344
48. Kaplan SL, Abrams CAL, Bell JJ, Conte FA, Grumbach MM 1965 Serum growth hormone response to insulin-induced hypoglycemia in disorders of growth. J Pediatr 67:956-959
49. Kaplan SL, Abrams CA, Bell JJ, Conte FA, Grumbach MM 1968 Growth and growth hormone. I. Changes in serum level of growth hormone following hypoglycaemia in 134 children with growth retardation. Pediatr Res 2:43-63
50. Marin G, Domene HM, Barnes KM, Blackwell BJ, Cassorla FG, Cutler Jr GB 1994 The effects of estrogen priming and puberty on the growth hormone response to standardised treadmill exercise and arginine-insulin in normal girls and boys. J Clin Endocrinol Metab 79:537-541
51. Zadik Z, Chalew SA, Kowarski A 1990 Assessment of growth hormone secretion in normal stature children using 24 hour integrated concentration of GH and pharmacological stimulation. J Clin Endocrinol Metab 71:932-936
52. Ghigo E, Bellone J, Aimaretti G, Bellone S, Loche S, Cappa M, Bartolotta E, Dammacco F, Camanni F 1996 Reliability of provocative tests to assess growth hormone secretory status. Study in 472 normally growing children. J Clin Endocrinol Metab 81:3323-3327
53. Buckler JMH 1972 Exercise as a screening test for growth hormone release. Acta Endocrinol (Copenh) 69:219-229
54. de San Lazaro C, Parkin JM, Turner SJ 1984 Treadmill exercise test in short children. Arch Dis Child 59:1179-1181
55. Nicoll AG, Smail PJ, Forsyth CC 1984 Exercise test for growth hormone deficiency. Arch Dis Child 59:1177-1178
56. Greene SA, Torresani T, Prader A 1987 Growth hormone response to a standardised exercise test in relation to puberty and stature. Arch Dis Child 62:53-56
57. Thompson RG, Rodriguez A, Kowarski AA, Blizzard RM 1972 Growth hormone: metabolic clearance rates, integrated concentrations and production rates in normal adults and the effect of prednisone. J Clin Invest 51:3193-3199
58. Zadik Z, Chalew SA, Gilula Z, Kowarski AA 1990 Reproducibility of growth hormone testing procedures: a comparison between 24 hour integrated concentration and pharmacological stimulation. J Clin Endocrinol Metab 71:1127-1130
59. Zadik Z, Chalew SA, Raiti S, Kowarski AA 1985 Do short children secrete insufficient growth hormone? Pediatrics 76:355-360
60. Rose SR, Ross JL, Uriarte M, Barnes KM, Cassorla FG, Cutler Jr GB 1988 The advantage of measuring stimulated as compared with spontaneous growth hormone levels in the diagnosis of growth hormone deficiency. N Engl J Med 319:201-207
61. Donaldson DL, Pan F, Hollowell JG, Stevenson JL, Gifford RA, Moore WV 1991 Reliability of stimulated and spontaneous growth hormone levels for identifying the child with low GH secretion. J Clin Endocrinol Metab 72:647-652
62. Spiliotis BE, August GP, Hung W, Sonis W, Mendelson W, Bercu BB 1984 Growth hormone neurosecretory dysfunction: a treatable cause of short stature. JAMA 251:2223-2230
63. Bercu BB, Shulman D, Root AW, Spiliotis BE 1986 Growth hormone provocative testing frequently does not reflect endogenous GH secretion. J Clin Endocrinol Metab 63:709-716
64. Blatt J, Bercu BB, Gillin JC, Mendelson WB, Poplack MD 1984 Reduced pulsatile growth hormone secretion in children after therapy for acute lymphoblastic leukaemia. J Pediatr 104:182-186
65. Saini S, Hindmarsh PC, Matthews DR, Pringle PJ, Jones J, Preece MA, Brook CGD 1991 Reproducibility of 24 hour serum growth hormone profiles in man. Clin Endocrinol (Oxf) 34:455-462
66. Albertsson-Wikland K, Rosberg S 1992 Reproducibility of 24 hour growth hormone profiles in children. Acta Endocrinol (Copenh) 126:109-112
67. Oerter KE, Sobel AM, Rose SR, Cristiano A, Malley JD, Cutler Jr GB, Baron J 1992 Combining insulin-like growth factor-I and mean spontaneous nighttime growth hormone levels for the diagnosis of growth hormone deficiency. J Clin Endocrinol Metab 75:1413-1420
68. Sukegawa I, Hizuka N, Takano K, Asakawa K, Horikawa R, Hashida S, Ishikawa E, Mohri ZI, Murakami Y, Shizume K 1988 Urinary growth hormone measurements are useful for evaluating endogenous GH secretion. J Clin Endocrinol Metab 66:1119-1123
69. Girard J, Fischer-Wasels T 1990 Measurement of urinary growth hormone. A noninvasive method to assess the growth hormone status. Horm Res 33 [Suppl 4]:12-18
70. Walker JM, Wood PJ, Williamson S, Betts PR, Evans AJ 1990 Urinary growth hormone excretion as a screening test for growth hormone deficiency. Arch Dis Child 65:89-92
71. Granada ML, Sanmarti A, Lucas A, Salinas I, Cuatrecasas JM, Foz M, Carrascosa A, Audi L 1992 Clinical usefulness of urinary growth hormone measurements in normal and short children according to different expressions of urinary growth hormone data. Pediatr Res 32:73-76
72. Kida K, Ito T, Hayashi M, Kaino Y, Goto Y, Ikeuchi M, Matsuda H 1992 Urinary excretion of human growth hormone in children with short stature: correlation with pituitary secretion of human growth hormone. J Pediatr 120:233-237
73. Skinner AM, Clayton PE, Price DA, Addison GM, Soo A 1993 Urinary growth hormone excretion in the assessment of children with disorders of growth. Clin Endocrinol (Oxf) 39:201-206
74. Crowne EC, Wallace WH, Shalet SM, Addison GM, Price DA 1992 Relationship between urinary and serum growth hormone and pubertal status. Arch Dis Child 67:91-95
75. Pirazzoli P, Mandini M, Zucchini S, Gualandi S, Vignutelli L, Capelli M, Cacciari E 1996 Urinary growth hormone estimation in diagnosing severe growth hormone deficiency. Arch Dis Child 75:228-231
76. Tillmann V, Buckler JMH, Kibirige MS, Price DA, Shalet SM, Wales JKH, Addison MG, Gill MS, Whatmore AJ, Clayton PE 1997 Biochemical tests in the diagnosis of childhood growth hormone deficiency. J Clin Endocrinol Metab 82:531-535
77. Daughaday WH, Rotwein P 1989 Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocr Rev 10:68-91
78. Rosenfeld RG, Lamson G, Pham H, Oh Y, Conover C, De-Leon DD, Donovan SM, Ocrant I, Guidice L 1990 Insulin-like growth factor binding proteins. Recent Prog Horm Res 46:99-163
79. Powell DR, Rosenfeld RG, Baker BK, Liu F, Hintz RL 1986 Serum somatomedin levels in adults with chronic renal failure: the importance of measuring insulin-like growth factor I (IGF-I) and IGF-II in acid chromatographed uraemic serum. J Clin Endocrinol Metab 63:1186-1192
80. Rosenfeld RG, Gargosky SE 1996 Assays for insulin-like growth factors and their binding proteins: Practicalities and pitfalls. J Pediatr 128 [Suppl]S52-57
81. Soliman AT, Hassan AE, Aref MK, Hintz RL, Rosenfeld RG, Rogol AD 1986 Serum insulin-like growth factors I and II concentrations and growth hormone and insulin responses to arginine infusion in children with protein-energy malnutrition before and after nutritional rehabilitation. Pediatr Res 20:1122-1130
82. Baxter RC, Brown AS, Turtle JR 1982 Radioimmunoassay for somatomedin-C: comparison with radioreceptor assay in patients with growth disorders, hypothyroidism and renal failure. Clin Chem 28:488-495
83. Tamborlane WV, Hintz RL, Bergman M, Genel M, Felig P, Sherwin RS 1981 Insulin infusion pump treatment of diabetes: influence of improved metabolic control on plasma somatomedin levels. N Engl J Med 305:303-307
84. Luna AM, Wilson DM, Wibbelsman CJ, Brown RC, Nagashima RJ, Hintz RL, Rosenfeld RG 1983 Somatomedins in adolescence: a cross-sectional study of the effect of puberty on plasma insulin-like growth factor I and II levels. J Clin Endocrinol Metab 57:268-271
85. Rosenfield RI, Furlanetto R, Bock D 1983 Relationship of somatomedin C concentrations to pubertal changes. J Pediatr 103:723-728
86. Juul A, Bang P, Hertel NT, Main K, Dalgaard P, Jorgensen K, Muller J, Hall K, Skakkebaek NE 1994 Serum insulin-like growth factor-I in 1030 healthy children, adolescents and adults: relation to age, sex, stage of puberty, testicular size and body mass index. J Clin Endocrinol Metab 78:744-752
87. Blum WF 1992 Insulin-like growth factors and their binding proteins. In: Ranke MB (ed) Functional Endocrinologic Diagnostics in Children and Adolescents. Verlag, Mannheim, Germany, pp 102-117
88. Juul A, Skakkebaek NE 1997 Prediction of the outcome of growth hormone provocative testing in short children by measurement of serum levels of insulin-like growth factor 1 and insulin-like growth factor binding protein 3. J Pediatr 130:197-204
89. Moore DC, Ruvalcaba RHA, Smith EK, Kelley VC 1982 Plasma somatomedin-C as a screening test for growth hormone deficiency in children and adolescents. Horm Res 16:49-55
90. Reiter EO, Lovinger RD 1981 The use of commercially available somatomedin-C radioimmunoassay in patients with disorders of growth. J Pediatr 99:720-724
91. Rosenfeld RG, Wilson DM, Lee PDK, Hintz RL 1986 Insulin-like growth factors I and II in the evaluation of growth retardation. J Pediatr 109:428-433
92. Martin JL, Baxter RC 1986 Insulin-like growth factor binding protein from human plasma purification and characterisation. J Biol Chem 261:8754-8760
93. Furlanetto RW 1980 The somatomedin C binding protein: evidence for a heterologous subunit structure. J Clin Endocrinol Metab 51: 12-19
94. Baxter RC 1988 Characterisation of the acid-labile subunit of the growth hormone-dependent insulin-like growth factor binding protein complex. J Clin Endocrinol Metab 67:265-272
95. Blum WF, Ranke MB, Kietzmann K, Gauggel E, Zeisel HJ, Bierich JR 1990 A specific radioimmunoassay for the growth hormone-dependent somatomedin-binding protein: its use for diagnosis of GH deficiency. J Clin Endocrinol Metab 70:1292-1298
96. Hasegawa Y, Hasegawa T, Aso T, Kotoh S, Nose O, Ohyama Y, Araki K, Tanaka T, Saisyo S, Yokoya S, Nishi Y, Miyamoto S, Sasaki N, Kurimoto F, Stene M, Tsuchiya Y 1994 Clinical utility of insulin-like growth factor binding protein-3 in the evaluation and treatment of short children with suspected growth hormone deficiency. Eur J Endocrinol 131:27-32
97. Rosenfeld RG, Pham H, Cohen P, Fielder P, Gargosky SE, Muller H, Nonoshita L, Oh Y 1994 Insulin-like growth factor binding proteins and their regulation. Acta Paediatr [Suppl] 399:154-158
98. Phillip M, Chalew SA, Kowarski AA, Stene MA 1993 Plasma IGFBP-3 and its relationship with quantitative growth hormone secretion in short children. Clin Endocrinol (Oxf) 39:427-432
99. Cianfarani S, Boemi S, Spagnoli A, Cappa M, Argiro G, Vaccaro F, Manca Bitti ML, Boscherini B 1995 Is IGF binding protein-3 assessment helpful for the diagnosis of GH deficiency? Clin Endocrinol (Oxf) 43:43-47
100. Nunez SB, Municchi G, Barnes KM, Rose SR 1996 Insulin-like growth factor-I and IGF-binding protein-3 concentrations compared to stimulated and night growth hormone in the evaluation of short children - a clinical research center study. J Clin Endocrinol Metab 81:1927-1932
101. Sklar C, Sarafoglou K, Whittam E 1993 Efficacy of insulin-like growth factor binding protein-3 in predicting the growth hormone response to provocative testing in children treated with cranial irradiation. Acta Endocrinol (Copenh) 129:511-515
102. Smith WJ, Nam TJ, Underwood LE, Busby WH, Celnicker A, Clemmons DR 1993 Use of insulin-like growth factor-binding protein-2 (IGFBP-2), IGFBP-3 and IGF-I for assessing growth hormone status in short children. J Clin Endocrinol Metab 77:1294-1299
103. Clemmons DR, Snyder DK, Busby WH 1991 Variables controlling the secretion of insulin-like growth factor binding protein-2 in normal human subjects. J Clin Endocrinol Metab 73:727-733
104. Guevara-Aguirre J, Rosenbloom AL, Fieldre PJ, Diamond FB, Rosenfeld RG 1993 Growth hormone receptor deficiency in Ecuador: clinical and biochemical phenotype in two populations. J Clin Endocrinol Metab 76:417-423
105. Savage MO, Blum WF, Ranke MB, Postel-Vinay MC, Cotterill AM, Hall K, Chatelain PG, Preece MA, Rosenfeld RG 1993 Clinical features and endocrine status in patients with growth hormone insensitivity (Laron Syndrome). J Clin Endocrinol Metab 77:1465-1471
106. Rosenfeld RG, Rosenbloom AL, Guevara-Aguirre J 1994 Growth hormone insensitivity due to primary GH receptor deficiency. Endocr Rev 15:369-390
107. Gelato MC, Malozowski S, Caruso-Nicoletti M, Ross JL, Pescovitz OH, Rose S, Loriaux DL, Cassorla F, Merriam GR 1986 Growth hormone responses to GH-releasing hormone during pubertal development in normal boys and girls: comparison to idiopathic short stature and GH deficiency. J Clin Endocrinol Metab 63:174-179
108. Butenandt O 1989 Diagnostic value of growth hormone releasing hormone tests in short children. Acta Paediatr Scand Suppl 349: 93-99
109. Muller EE, Nistico G 1989 Neurotransmitter regulation of the anterior pituitary. In: Muller EE, Nistico G (eds) Brain Messengers and the Pituitary. Academic Press, San Diego, pp 404-537
110. Ghigo E 1992 Neurotransmitter control of growth hormone secretion. In: De la Cruz (ed) Regulation of Growth Hormone and Somatic Growth. Excerpta Medica, Amsterdam, pp 103-136
111. Valetto MR, Bellone J, Baffoni C, Savio P, Aimaretti G, Gianotti L, Arvat E, Camanni F, Ghigo E 1996 Reproducibility of the growth hormone response to stimulation with growth hormone-releasing hormone plus arginine during lifespan. Eur J Endocrinol 135:568-572
112. Tzanela M, Guyda H, Van Vliet G, Tannenbaum GS 1996 Somatostatin pretreatment enhances growth hormone responsiveness to GH-releasing hormone: a potential new diagnostic approach to GH deficiency. J Clin Endocrinol Metab 81:2487-2494
113. Maghnie M, Valtorta A, Moretta A, Larizza D, Preti P, Palladini G, Calcante S, Seven F 1993 Diagnosing growth hormone deficiency: the value of short term hypocaloric diet. J Clin Endocrinol Metab 77:1372-1378
114. Werther GA 1996 Growth hormone measurements vs. auxology in treatment decisions: the Australian experience. J Pediatr [Suppl] 128:547-51
115. Cowell CT, Dietsch S, Greenacre P 1996 Growth hormone therapy for 3 years: the OZGROW experience. J Pediatr Child Health 32: 86-93
116. Jenkins RC, Ross RJM 1996 Growth hormone therapy for protein catabolism. Q J Med 89:813-819
117. Souberbielle JC, Zucker JM, Rappaport R, Brauner R 1994 Nonparallel changes of growth hormone (GH) and insulin-like growth factor-1, insulin-like growth factor binding protein-3 and GH-binding protein, after craniospinal irradiation and chemotherapy. J Clin Endocrinol Metab 78:597-601
118. Takahashi Y, Kaji H, Okimura Y, Goji K, Abe H, Chihara K 1996 Short stature caused by a mutant growth hormone. N Engl J Med 334:432-436
119. Laron Z 1993 Laron syndrome: from description to therapy. Endocrinologist 3:21-28
120. Rosenfeld RG, Rosenbloom AL, Guevara-Aguirre J 1994 Growth hormone (GH) insensitivity due to primary GH receptor deficiency. Endocr Rev 15:369-390
121. Woods KA, Camacho-Hubner C, Savage MO, Clark AJL 1996 Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor 1 gene. N Engl J Med 335:1363-1367
122. Buchanan CR, Maheshwari HG, Norman MR, Morrell DJ, Preece MA 1991 Laron-type dwarfism with apparently normal high affinity serum growth hormone binding protein. Clin Endocrinol (Oxf) 35:179-185
123. Goddard AD, Covello R, Luoh SM, Clackson T, Attie KM, Gesundheit N, Rundle AC, Wells JA, Carlsson LMS 1995 Mutations of the growth hormone receptor in children with idiopathic short stature. N Engl J Med 333:1093-1098
124. Dickinson WP, Berry DH, Dickinson L, Irvin M, Schedewie H, Fiser RH, Elders MJ 1978 Differential effects of cranial radiation on growth hormone response to arginine and insulin infusion. J Pediatr 92:754-757
125. Chrousos GO, Poplack D, Brown T, O'Neill D, Schwade J, Bercu BB 1982 Effects of cranial irradiation on hypothalamic-adenohypophyseal function; abnormal growth hormone secretory dynamics. J Clin Endocrinol Metab 54:1135-1139
126. Schoenle EJ, Zapf J, Prader A, Torresani T, Werder EA, Zachmann M 1995 Replacement of growth hormone in normally growing GH deficient patients operated for craniopharyngioma. J Clin Endocrinol Metab 80:374-378
127. Reiter JC, Craen M, Van Vliet G 1991 Decreased growth hormone response to growth hormone releasing hormone in Turner's syndrome: relation to body weight and adiposity. Acta Endocrinol (Copenh) 125:38-42
128. Salomon F, Cuneo RC, Hesp R, Sonksen PH 1989 The effects of treatment with recombinant growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med 321:1797-1803
129. DeBoer H, Blok GJ, Voerman HJ, DeVries PMJM, Van der Veen EA 1992 Body composition in adult growth hormone deficient men, assessed by anthropometry and bioimpedance analysis. J Clin Endocrinol Metab 75:833-837
130. Kaufman JM, Taelman P, Vermeulen A, Vandeweghe M 1992 Bone mineral status in growth hormone deficient males with isolated and multiple pituitary deficiencies of childhood onset. J Clin Endocrinol Metab 74:118-123
131. O'Halloran DJ, Tsatsoulis A, Whitehouse RW, Holmes SJ, Adams JE, Shalet SM 1993 Increased bone density after recombinant human growth hormone (GH) therapy in adults with isolated GH deficiency. J Clin Endocrinol Metab 76:1344-1348
132. DeBoer H, Blok GJ, Van Lingen A, Teule GJJ, Lips P, Van der Veen EA 1994 Consequences of childhood-onset growth hormone deficiency of adult bone mass. J Bone Miner Res 9:1319-1326
133. Johansson AG, Burman P, Westmark K, Ljunghall S 1992 The bone mineral density in acquired growth hormone deficiency correlates with circulating levels of insulin-like growth factor I. J Intern Med 232:447-452
134. Holmes SJ, Economou G, Whitehouse RW, Adams JE, Shalet SM 1994 Reduced bone mineral density in patients with adult onset growth hormone deficiency. J Clin Endocrinol Metab 78:669-674
135. Libber SM, Plotnick LP, Johanson AJ, Blizzard RM, Kwiterovich PO, Migeon CJ 1990 Long-term follow-up of hypopituitary patients treated with human growth hormone. Medicine 69:46-55
136. Wuster CHR, Slenczka E, Ziegler R 1991 Arteriosklerose bei konventionell substituierter hypophysenvorderlappeninsuffiziez: bedarf einer zusatzlichen Wachstumshormonsubstitution? Klin Wochenschr 69:769-773
137. Cuneo RC, Salomon F, Watts GF, Hesp R, Sonksen PH 1993 Growth hormone treatment improves serum lipids and lipoproteins in adults with growth hormone deficiency. Metabolism 42: 1519-1523
138. Beshyah SA, Henderson A, Niththyanathan R, Sharp P, Richmond W, Johnston DG 1994 Metabolic abnormalities in growth hormone deficient adults. II. Carbohydrate tolerance and lipid metabolism. Endocrinol Metab 1:173-180
139. Johansson JO, Fowelin J, Landin K, Lager I, Bengtsson BA 1995 Growth hormone deficient adults are insulin resistant. Metabolism 44:1126-1129
140. Johansson JO, Landin K, Tengborn L, Rosen T, Bengtsson BA 1994 High fibrinogen and plasminogen activator inhibitor activity in growth hormone deficient adults. Arterioscler Thromb 14:434-437
141. Amato G, Carella C, Fazio S, LaMontagna G, Cittadini A, Sabatini D, Marciano-Mone C, Sacca L, Bellastella A 1993 Body composition, bone metabolism and heart structure and function in growth hormone (GH)-deficient adults before and after GH replacement at low doses. J Clin Endocrinol Metab 77:1671-1676
142. Merola B, Cittadini A, Colao A, Longobardi S, Fazio S, Sabatini D, Sacca L, Lombardi G 1993 Cardiac structural and functional abnormalities in adult patients with growth hormone deficiency. J Clin Endocrinol Metab 77:1658-1661
143. Shahi M, Beshyah SA, Hackett D, Sharp PS, Johnston DG, Foale RA 1992 Myocardial dysfunction in treated adult hypopituitarism: a possible explanation for increased cardiovascular mortality. Br Heart J 67:92-96
144. Valcavi R, Gaddi O, Zini M, Laviocoli M, Mellino U, Portioli I 1995 Cardiac performance and mass in adults with hypopiruitarism: effects of one year of growth hormone treatment. J Clin Endocrinol Metab 80:659-666
145. Nass R, Huber RM, Klaus V, Muller OA, Schopohl J, Strasburger C 1995 Effect of growth hormone (hGH) replacement therapy on physical work capacity and cardiac and pulmonary function in patients with hGH deficiency acquired in adulthood. J Clin Endocrinol Metab 80:552-557
146. Cuneo RC, Salomon F, Wiles CM, Hesp R, Sonksen PH 1991 Growth hormone treatment in growth hormone deficient adults. II. Effects on exercise performance. J Appl Physiol 70:695-700
147. McGauley GA 1989 Quality of life assessment before and after growth hormone treatment in adults with growth hormone deficiency. Acta Pediatr Scand Suppl 356:70-72
148. Bjork S, Jonsson B, Westphal O, Levin JE 1989 Quality of life of adults with growth hormone deficiency: a controlled study. Acta Pediatr Scand Suppl 356:55-59
149. Rosen T, Wiren L, Wilhelmsen L, Wiklund I, Bengtsson BA 1994 Decreased psychological well-being in adult patients with growth hormone deficiency. Clin Endocrinol (Oxf) 40:111-116
150. Attanasio AF, Lamberts SWJ, Matranga AMC, Birkett MA, Bates PC, Valk NK, Hilsted J, Bengtsson BA, Strasburger CJ 1997 Adult growth hormone deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment. J Clin Endocrinol Metab 82:82-88
151. Klibanski A 1987 Nonsecreting pituitary tumours. Endocrinol Metab Clin North Am 16:793-804
152. Littley MD, Shalet SM, Beardwell CG, Ahmed SR, Applegate G, Sutton ML 1989 Hypopituitarism following external radiotherapy for pituitary rumours in adults. Q J Med 70:145-160
153. Stewart PM, Come J, Seckl JR, Edwards CR, Padfield PL 1988 A rational approach for assessing the hypothalamo-pituitary-adrenal axis. Lancet 1:1208-1210
154. Clayton RN 1996 Short synacthen test vs. insulin stress for assessment of the hypothalamo-pituitary-adrenal axis: controversy revisited. Clin Endocrinol (Oxf) 44:147-149
155. Hurel SJ, Thompson CJ, Watson MJ, Harris MM, Baylis PH, Kendall-Taylor P 1996 The short synacthen and insulin stress tests in the assessment of the hypothalamic-pituitary-adrenal axis. Clin Endocrinol (Oxf) 44:141-146
156. Cain JP, Williams GH, Dluhy RG 1972 Glucagon-initiated human growth hormone release: a comparative study. Can Med Assoc J 107:617-622
157. Lin T, Tucci JR 1974 Provocative tests of growth hormone release. A comparison of results with seven stimuli. Ann Intern Med 80: 464-469
158. Sutton J, Lazarus L 1976 Growth hormone in exercise: comparison of physiological and pharmacological stimuli. J Appl Physiol 41: 523-527
159. Eddy RL, Gilliland PF, Ibarra JD, McMurry JF, Thompson JQ 1974 Human growth hormone release: comparison of provocative test procedures. Am J Med 56:179-185
160. Vahl N, Jorgensen JOL, Jurik AG, Christiansen JS 1996 Abdominal adiposity and physical fitness are major determinants of the age associated decline in stimulated GH secretion in healthy adults. J Clin Endocrinol Metab 81:2209-2215
161. Rahim A, Toogood AA, Shalet SM 1996 The assessment of growth hormone status in normal young adult males using a variety of provocative agents. Clin Endocrinol (Oxf) 45:557-562
162. Tapanainen P, Knip M, Lautala P, Leppaluoto J 1988 Variable plasma growth hormone (GH)-releasing hormone and GH responses to clonidine, L-dopa and insulin in normal men. J Clin Endocrinol Metab 67:845-849
163. Koppeschaar HPF, tenHorn CD, Thijssen JHH, Page MD, Dieguez C, Scanlon MF 1992 Differential effect of arginine on growth hormone releasing hormone and insulin induced growth hormone secretion. Clin Endocrinol (Oxf) 36:487-490
164. Hoeck HC, Vestergaard P, Jakobsen PE, Laurberg P 1995 Tests of growth hormone secretion in adults: poor reproducibility of the insulin tolerance test. Eur J Endocrinol 133:305-312
165. Parker ML, Hammond JM, Daughaday WH 1967 The arginine provocative test: an aid in the diagnosis of hyposomatotropinism. J Clin Endocrinol Metab 27:1129-1136
166. Merimee TJ, Burgess JA, Rabinowitz D 1996 Sex-determined variation in serum insulin and growth hormone response to amino acid stimulation. J Clin Endocrinol Metab 26:791-793
167. Jorgensen JOL, Thuesen L, Ingemann-Hansen T, Pederson SA, Jorgensen J, Skakkebaek NE, Christiansen JS 1989 Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet 1:1221-1225
168. Binnerts A, Swart GR, Wilson JHP, Hoogerbrugge N, Pols HAP, Birkenhager JC, Lamberts SWJ 1992 The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis as well as on body composition. Clin Endocrinol (Oxf) 37:79-87
169. Bengtsson BA, Eden S, Lonn L, Kvist H, Stokland A, Linstedt G, Bosaeus I, Tolli J, Sjostrom L, Isaksson OGP 1993 Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. J Clin Endocrinol Metab 76:309-317
170. Orme SM, Sebastian JP, Oldroyd B, Stewart SP, Grant PJ, Stickland MH, Smith MA, Belchetz PE 1992 Comparison of measures of body composition in a trial of low dose growth hormone replacement therapy. Clin Endocrinol (Oxf) 37:453-459
171. Whitehead HM, Boreham C, McIlrath EM, Sheridan B, Kennedy L, Atkinson AB, Hadden DA 1992 Growth hormone treatment of adults with growth hormone deficiency: results of a 13-month placebo controlled cross-over study. Clin
172. Thorner MO, Bengtsson BA, Ho KY, Albertsson-Wikland K, Christiansen JS, Faglia G, Irie M, Isaksson O, Jorgensen JO, Ranke M, Rosenfeld R, Shalet SM, Takano K, Van der Veen EA, Weissberger A 1995 The diagnosis of growth hormone deficiency (GHD) in adults. J Clin Endocrinol Metab 80:3097-3098
173. Hoffman DM, O'Sullivan AJ, Baxter RC, Ho KY 1994 Diagnosis of growth hormone deficiency in adults. Lancet 343:1064-1068
174. Jones SL, Trainer PJ, Perry L, Wass JAH, Besser GM, Grossman A 1994 An audit of the insulin tolerance test in adult subjects in an acute investigation unit over one year. Clin Endocrinol (Oxf) 41: 123-128
175. Hoffman DM, Ho KKY 1996 Diagnosis of GH deficiency in adults. In Juul A, Jorgenson JOL (eds) Growth Hormone in Adults. Cambridge University Press, Cambridge, U.K., pp 168-185
176. Weissberger AJ, Verkikiou K, Sonksen PH 1994 Diagnosis of growth hormone deficiency in adults. Lancet 344:483
177. Bates AS, Evans AJ, Jones P, Clayton RN 1995 Assessment of GH status in adults with GH deficiency using serum growth hormone, serum insulin-like growth factor-I and urinary growth hormone excretion. Clin Endocrinol (Oxf) 42:425-430
178. Toogood AA, Nass RM, Pezzoli SS, O'Neill PA, Thorner MO, Shalet SM 1997 Preservation of growth hormone pulsatility despite pituitary pathology, surgery and irradiation. J Clin Endocrinol Metab 82:2215-2221
179. Reutens AT, Hoffman DM, Leung KC, Ho KKY 1995 Evaluation and application of a highly sensitive assay for serum growth hormone (GH) in the study of adult GH deficiency. J Clin Endocrinol Metab 80:480-485
180. Reutens AT, Veldhuis JD, Hoffman DM, Leung KC, Ho KKY 1996 A highly sensitive growth hormone (GH) enzyme-linked immunosorbent assay uncovers increased contribution of a tonic mode of GH secretion in adults with organic GH deficiency. J Clin Endocrinol Metab 81:1591-1597
181. Holmes SJ 1995 Growth Hormone Replacement in Adults with Growth Hormone Deficiency. MD Thesis. University of London, London, pp 141-152
182. Beshyah SA, Anyaoku V, Newton P, Johnston DG 1994 Metabolic abnormalities in growth hormone deficient adults. 1. Serum insulin-like growth factor-I. Endocrinol Metab 1:167-172
183. Janssen YJH, Frolich M, Roelfsema F 1997 A low starting dose of genotropin in growth hormone deficient adults. J Clin Endocrinol Metab 82:129-135
184. Williams T, Berelowitz M, Joffe SN, Thorner MO, Rivier J, Vale W, Frohman LA 1984 Impaired growth hormone response to growth hormone-releasing factor in obesity. A pituitary defect reversed with weight reduction. N Engl J Med 311:1403-1407
185. Rasmussen MH, Hvidberg A, Juul A, Main KM, Gotfredsen A, Skakkebaek NE, Hilsted J 1995 Massive weight loss restores 24 hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects. J Clin Endocrinol Metab 80:1407-1415
186. Veldhuis JD, Iranmanesh A, Ho KKY, Waters MJ, Johnson ML, Lizarralde G 1991 Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man. J Clin Endocrinol Metab 72:51-59
187. Iranmesh A, Lizarralde G, Veldhuis JD 1991 Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. J Clin Endocrinol Metab 73:1081-1088
188. Weltman A, Weltman JY, Hartman ML, Abbott RD, Rogol AD, Evans WS, Veldhuis JD 1994 Relationship between age, percentage body-fat, fitness and 24 hour growth hormone release in healthy young adults: effects of gender. J Clin Endocrinol Metab 78:543-548
189. Rudman D, Kutner MH, Rogers CM, Lubin MF, Flemming GA, Bain RP 1981 Impaired growth hormone secretion in the adult population. J Clin Invest 67:1361-1369
190. Gama R, Teele JD, Marks V 1990 The effect of synthetic very low calorie diets on the GH-IGF-I axis in obese subjects. Clin Chim Acta 188:31-38
191. Poehlman ET, Copeland KC 1990 Influence of physical activity on insulin-like growth factor-I in healthy younger and older men. J Clin Endocrinol Metab 71:1468-1473
192. Weaver JU, Holly JMP, Kopelman PG, Noonan K, Giadom CG, White N, Virdee S, Wass JAH 1990 Decreased sex hormone binding globulin (SHBG) and insulin-like growth factor binding protein (IGFBP-I) in extreme obesity. Clin Endocrinol (Oxf) 33:415-422
193. Loche S, Pintor C, Cappa M, Ghigo E, Puggioni R, Locatelli V, Muller EE 1989 Pyridostigmine counteracts the blunted growth hormone response to growth hormone-releasing hormone in obese children. Acta Endocrinol (Copenh) 120:624-628
194. Landin-Wilhelmsen K, Wilhelmsen L, Lappas G, Rosen T, Lindstedt G, Lundberg PA, Bengtsson BA 1994 Serum insulin-like growth factor-I in a random population sample of men and women: relation to age, sex, smoking habits, coffee consumption and physical activity, blood pressure, and concentrations of plasma lipids, fibrinogen, parathyroid hormone and osteocalcin. Clin Endocrinol (Oxf) 41:351-357
195. Imaki T, Shibasaki T, Shizume K, Masuda A, Hotta M, Kiyosawa Y, Jibiki K, Demura H, Tsushima T, Ling N 1985 The effect of free fatty acids on growth hormone (GH)-releasing hormone-mediated GH secretion in man. J Clin Endocrinol Metab 60:290-293
196. Blackard WG, Hull EW, Lopez A 1971 Effect of lipids on growth hormone secretion in humans. J Clin Invest 50:1439-1443
197. Lee EJ, Nam SY, Kim KR, Lee HC, Cho JH, Nam MS, Song YD, Lim SK, Huh KB 1995 Acipimox potentiates growth hormone (GH) response to GH-releasing hormone with or without pyridostigmine by lowering serum free fatty acid in normal and obese subjects. J Clin Endocrinol Metab 80:2495-2498
198. Cordido F, Peino R, Penalva A, Alvarez CV, Casanueva FF, Dieguez C 1996 Impaired growth hormone secretion in obese subjects is partially reversed by acipimox-mediated plasma free fatty acid depression. J Clin Endocrinol Metab 81:914-918
199. Maccario M, Procopio M, Grottoli S, Oleandri SE, Boffano GM, Taliano M, Camanni F, Ghigo E 1996 Effect of acipimox, an antilipolytic drug, on the growth hormone (GH) response to GH-releasing hormone alone or combined with arginine in obesity. Metabolism 45:342-346
200. Ho KKY, Rasmussen MH, Hoffman DM, Hilsted J, Leung KC, How growth hormone deficient are the obese? Program of the 78th Annual Meeting of The Endocrine Society, San Francisco, CA, 1996, p 115 (Abstract)
201. Finkelstein JW, Roffwarg HP, Boyar RM, Kream J, Hellman L 1972 Age-related change in the twenty-four hour spontaneous secretion of growth hormone. J Clin Endocrinol Metab 35:665-670
202. Dudl RJ, Ensinck JW, Palmer HE, Williams RH 1973 Effect of age on growth hormone secretion in man. J Clin Endocrinol Metab 37:11-16
203. Prinz PN, Weitzman ED, Cunningham GR, Karacan I 1983 Plasma growth hormone during sleep in young and aged men. J Gerontol 38:519-524
204. Ho KKY, Evans WS, Blizzard RM, Veldhuis JD, Merriam GR, Samojlik E, Furlanetto R, Rogol AD, Kaiser DL, Thorner MO 1987 Effects of sex and age on the 24 hour profile of growth hormone secretion in man: importance of endogenous oestradiol concentrations. J Clin Endocrinol Metab 64:51-58
205. Rudman D 1985 Growth hormone, body composition and aging. J Am Geriatr Soc 33:800-807
206. Mindermann T, Wilson CB 1994 Age-related and gender-related occurrence of pituitary adenomas. Clin Endocrinol (Oxf) 40:111-116
207. Toogood AA, O'Neill PA, Shalet SM 1996 Beyond the somatopause: growth hormone deficiency in adults over the age of 60 years. J Clin Endocrinol Metab 81:460-465
208. Toogood AA, O'Neill PA, Shalet SM, Markers of growth hormone (GH) status in adults over 60 years old with and without hypothalamic-piruitary disease. Program of the 78th Annual Meeting of The Endocrine Society, San Francisco, CA, 1996, p 759 (Abstract)
209. Clayton PE, Price DA, Shalet SM 1987 Growth hormone state after completion of treatment with growth hormone. Arch Dis Child 62:222-226
210. Cacciari E, Tassoni P, Parisi G, Pirazzoli P, Zucchini S, Mandini M, Cicognani A, Balsamo A 1992 Pitfalls in diagnosing impaired growth hormone (GH) secretion: retesting after replacement therapy of 63 patients defined as GH deficient. J Clin Endocrinol Metab 74:1284-1289
211. Wacharasindhu S, Cotterill AM, Camacho-Hubner E, Besser GM, Savage MO 1996 Normal growth hormone secretion in growth hormone insufficient children retested after completion of linear growth. Clin Endocrinol (Oxf) 45:553-556
212. Longobardi S, Merola B, Pivonello R, Relia F, Somma C, Colao A, Ghigo E, Camanni F, Lombardi G 1996 Re-evaluation of growth hormone (GH) secretion in 69 adults diagnosed as GH deficient patients during childhood. J Clin Endocrinol Metab 81:1244-1247
213. Nicolson A, Toogood AA, Rahim A, Shalet SM 1996 The prevalence of severe growth hormone deficiency in adults who received growth hormone replacement in childhood. Clin Endocrinol (Oxf) 44:311-316
214. Tauber M, Moulin P, Pienkowski C, Jouret B, Rochiccioli P 1997 Growth hormone (GH) retesting and auxological data in 131 GH-deficient patients after completion of treatment. J Clin Endocrinol Metab 82:352-356
215. Juul A, Kastrup KW, Pedersen SA, Skakkebaek NE 1997 Growth hormone (GH) provocative retesting of 108 young adults with childhood-onset GH deficiency and the diagnostic value of insulin-like growth factor 1 (IGF-I) and IGF-binding protein-3. J Clin Endocrinol Metab 82:1195-1201
216. Shalet SM 1993 Radiation and pituitary dysfunction. N Engl J Med 328:131-133
217. Anderson M, Hansen TB, Stoving RK, Bertelsen J, Hangaard J, Hyltoft Petersen P, Hagen C 1996 The pyridostigmine-growth hormone-releasing hormone test in adults. The reference interval and a comparison with the insulin tolerance test. Endocrinol Metab 3:197-206
218. Ghigo E, Aimaretti G, Gianotti L, Bellone J, Arvat E, Camanni F 1996 New approach to the diagnosis of growth hormone deficiency in adults. Eur J Endocrinol 134:352-356
219. Brennan BMD, Rahim A, Mackie EM, Eden OB, Shalet SM 1998 Growth hormone status in adults treated for acute lymphoblastic leukaemia in childhood. Clin Endocrinol (Oxf), in press